Nan Fung Group Holdings LTD Bei Gene, Ltd. Transaction History
Nan Fung Group Holdings LTD
- $52.7 Million
- Q2 2025
A detailed history of Nan Fung Group Holdings LTD transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 15,722 shares of BGNE stock, worth $3.56 Million. This represents 6.76% of its overall portfolio holdings.
Number of Shares
15,722
Previous 15,722
-0.0%
Holding current value
$3.56 Million
Previous $3.56 Million
-0.0%
% of portfolio
6.76%
Previous 3.43%
Shares
5 transactions
Others Institutions Holding BGNE
# of Institutions
269Shares Held
32.2MCall Options Held
113KPut Options Held
106K-
Baker Bros. Advisors LP New York, NY8.8MShares$1.99 Billion20.22% of portfolio
-
Primecap Management CO Pasadena, CA5.09MShares$1.15 Billion0.94% of portfolio
-
Capital International Investors Los Angeles, CA4.89MShares$1.11 Billion0.2% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E91.03MShares$234 Million9.68% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.02MShares$231 Million0.03% of portfolio
About BeiGene, Ltd.
- Ticker BGNE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,700,000
- Market Cap $23.5B
- Description
- BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...